Channel Insider
AUGUST 29, 2024
Cybersecurity giant Check Point Software has announced plans to acquire Cyberint Technologies , a leader in external risk management. The deal is expected to significantly enhance Check Point’s Security Operations Center (SOC) capabilities and expand its managed threat intelligence offerings. The acquisition comes on the heels of a significant leadership change.
Mindmatrix
AUGUST 29, 2024
In today’s competitive business landscape, channel partnerships have emerged as a crucial strategy for driving growth and expanding market reach. As companies vie for dominance in each market segment of their respective industries, leveraging channel partnerships can offer significant advantages, such as accessing new customer segments, enhancing product offerings, and optimizing resource utilization.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Frost & Sullivan
AUGUST 29, 2024
Sustained growth in nutrition and wellness now hinges on the ability of companies to leverage emerging ingredients and technologies. Be it agrochemical solutions or wellness segments like hair care and nutraceuticals, this ecosystem is witnessing competitive intensity, rising demand, and a growing emphasis on sustainability and digitalization. The landscape is rich with opportunities, making this an exciting time for innovation and expansion.
TRG Blog
AUGUST 29, 2024
As the economy evolves rapidly, building an adaptable workforce is crucial for organisations seeking to stay ahead of change. Yet true talent acquisition requires more than filling vacancies; it demands a holistic approach that encompasses both current and future hiring needs.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Frost & Sullivan
AUGUST 29, 2024
By Benson Augustine, Program Manager – Mobility The Latin American brake replacement market for passenger cars and light commercial vehicles is undergoing significant transformation, driven by changing consumer preferences and intensified competition from low-cost imports. As the market landscape evolves, domestic brake products are expected to maintain a competitive edge through differentiation in positioning and brand identity, despite the increasing market pressures.
Partnership Management Hub brings together the best content for partnership management and strategic alliance professionals from the widest variety of industry thought leaders.
Frost & Sullivan
AUGUST 29, 2024
Transforming Digital Infrastructure with the Data Center Revolution Data center colocation services in India are experiencing a series of changes fuelled by the rising demand for robust data storage and processing from hyperscale cloud providers, over-the-top (OTT) platforms, content providers, and artificial intelligence (AI) companies. This shift is accelerated by advancements in 5G, Internet of Things (IoT), the proliferation of smartphones, and favourable government policies.
Channel Insider
AUGUST 29, 2024
Earlier in August, international IT solutions provider Fulcrum IT Partners announced it was acquiring Fortress and adding its capabilities , including its 24/7 U.S.-based SOC offering, into the Fulcrum portfolio of products and services. The acquisition is the latest in a series of purchases for the massive services provider, which has acquired several MSPs over the past several years to form one company with a variety of niche expertise and locations in the US and Canada as well as throughout E
Frost & Sullivan
AUGUST 29, 2024
As of April 2023, the global pharmaceutical R&D pipeline has over 6000 molecules in active clinical development phase, showing a 5.8% increase from 2022. However, the pharma/biopharma industry overall shows stagnant R&D activity. Total R&D expenditure is approximately $276.81 billion, with a modest 2.5% growth from 2023 to 2024. The Pharma industry is facing a declining average return on investment (ROI) for R&D, dropping to 1.2%, and peak sales per asset hovering just above $350
Expert insights. Personalized for you.
105 
Let's personalize your content